Is Pump Therapy for All with Type 1 Diabetes?

Fry A : Insulin delivery device technology 2012: where are we after 90 years?. J Diabetes Sci Technol, 2012; 6:947–953.

Alsaleh FM , Smith FJ , Keady S , Taylor KM : Insulin pumps: from inception to the present and toward the future. J Clin Pharm Ther, 2010; 35:127–138.

The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993; 329:977–986.

Renard E : Insulin pump use in Europe. Diabetes Technol Ther, 2010; 12(Suppl 1):S29–S32.

Miller KM , Foster NC , Beck RW , et al.: Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care, 2015; 38:971–978.

Boulet G , Halpern EM , Lovblom LE , et al.: Prevalence of insulin pump therapy and its association with measures of glycemic control: results from the Canadian study of longevity in type 1 diabetes. Diabetes Technol Ther, 2016; 18:298–307.

Campbell MS , Schatz DA , Chen V , et al.: A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience. Pediatr Diabetes, 2014; 15:110–117.

Golden SH , Brown T , Yeh HC , et al.: Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness. Review No. 57 (prepared by Johns Hopkins University Evidence-based Practice Center under Contract No. 290-2007-10061-I). AHRQ Publication No. 12-EHC036-EF. Rockville, MD. Agency for Healthcare Research and Quality. July 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm.

Canadian Agency for Drugs and Technologies in Health Rapid Response Report: Insulin Pumps for Adults with Type 1 Diabetes: A Review of Clinical Effectiveness, Cost-effectiveness and Guidelines. Ottawa, ON, 2015. Canadian review of effectiveness 2015PubMedHealth_PMH0084253.pdf.

Weiss R , Garg SK , Bode BW , et al.: Hypoglycemia reduction and changes in hemoglobin A1c in the ASPIRE in-home study. Diabetes Technol Ther, 2015; 17:542–547.

Maahs DM , Calhoun P , Buckingham BA , et al.: A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care, 2014; 37:1885–1891.

Battelino T , Omladic JS , Phillip M : Closed loop insulin delivery in diabetes. Best Pract Res Clin Endocrinol Metab, 2015; 29:315–325.

Russell SJ : Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Curr Opin Endocrinol Diabetes Obes, 2015; 22:106–111.

Buckingham B , Beck RW , Ruedy KJ , et al.: Effectiveness of early intensive therapy on beta-cell preservation in type 1 diabetes. Diabetes Care, 2013; 36:4030–4035.